Skip to main content
. 2013 Jan 15;7(1):11–16. doi: 10.5005/jp-journals-10008-1130

Table 2: Overview of outcome of survey questionnaire

Question      Timolol hemihydrate      Timolol in sorbate      p-value     
     N          Mean score           N          Mean score          
1. Burning/stinging?      64          1.1 ± 1.1           39          2.4 ± 1.4      <0.001     
2. Overall tolerability?      64          0.8 ± 0.8           39          1.0 ± 0.9      0.28     
3. Overall comfort?      64          0.8 ± 0.8           39          1.1 ± 1.0      0.14     
4. Tearing?      64          0.9 ± 1.0           39          1.6 ± 1.6      0.024     
5. Light sensitivity?      63          0.5 ± 0.7           38          0.4 ± 0.9      0.75     
6. Blurred vision?      64          0.7 ± 1.0           39          0.6 ± 1.0      0.69     
7. Disruption of daily activities?      63          0.1 ± 0.3           39          0.2 ± 0.5      0.53     
8. How long was disruption?      11          0.2 ± 0.4             7          0.1 ± 0.4      0.84     
10. Overall comfort vs other glaucoma medicines?      39          1.5 ± 0.9           26          1.6 ± 1.1      0.94     
Question 9                                   
response      Timolol hemihydrate           Timolol maleate in sorbate      Total     
1           5                5      10     
2           2                0        2     
6           2                1        3     
Total           9                6      15     
p-value**                          0.41          

*2-tailed p-value, t-test; **Chi-square test